Stocktoria
CURIS INC CRIS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-08-01
CURIS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.4M | $10.9M | $10.0M | $10.2M | $10.6M |
| Operating income | -$5.7M | -$44.5M | -$48.3M | -$53.0M | -$42.1M |
| Interest expense | — | — | — | — | $0 |
| Income tax | $0 | $0 | — | — | — |
| Net income | -$7.6M | -$43.4M | -$47.4M | -$56.7M | -$45.4M |
| EPS (diluted) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 |
| Operating cash flow | -$27.2M | -$39.6M | -$38.4M | -$54.3M | -$37.6M |
| Free cash flow | — | — | -$38.4M | -$54.8M | -$37.6M |
| Cash & equivalents | $5.1M | $20.0M | $26.7M | $19.7M | $40.0M |
| Total assets | $20.0M | $41.3M | $77.3M | $108.8M | $162.3M |
| Total liabilities | $14.5M | $47.3M | $57.6M | $62.3M | $71.6M |
| Shareholders' equity | $5.5M | -$6.0M | $19.7M | $46.6M | $90.7M |
Source: SEC EDGAR filings · CIK 0001108205 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.